| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exicure, Inc. (XCUR) has 3 insiders with recent SEC Form 4 filings, including 9 buys and 1 sell. XCUR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.60M | $5.36M | - | |
| Other | 301 | $1.0K | - | |
| 10% | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 22, 2019 | Mirkin Chad A. | Director, 10% Owner | Buy | 500 | $2.30 | $1,150.00 | +1.9% | |
| Mar 21, 2019 | Mirkin Chad A. | Director, 10% Owner | Buy | 1,000 | $2.43 | $2,430.00 | +3.9% | |
| Mar 19, 2019 | Giljohann David A | Chief Executive Officer | Buy | 7,000 | $2.40 | $16,800.00 | +42.0% | |
| Mar 18, 2019 | Mirkin Chad A. | Director, 10% Owner | Buy | 1,000 | $2.40 | $2,400.00 | +4.0% | |
| Mar 13, 2019 | Mirkin Chad A. | Director, 10% Owner | Buy | 2,200 | $2.50 | $5,500.00 | +9.7% | |
| Sep 26, 2017 | Giljohann David A | Chief Executive Officer | Buy | 16,666 | $3.00 | $49,998.00 | New | |
| Sep 26, 2017 | Venkatesan Jay | Director | Buy | 66,666 | $3.00 | $199,998.00 | +73.9% | |
| Sep 26, 2017 | Walt David R54 | Director | Buy | 268,333 | $3.00 | $804,999.00 | +53.7% | |
| Sep 26, 2017 | Tompkins Mark N.88 | Former Director And 10% Owner | Buy | 166,667 | $3.00 | $500,001.00 | +10.0% | |
| Jun 15, 2017 | Jacobs Ian Seth | President, Secretary, CEO, CFO | Sell | 35,000 | $0.03 | $875.00 | -35.0% |